Smith & Nephew Returns to the M&A Market

Smith & Nephew Returns to the M&A Market

It’s been over a year since Smith & Nephew plc (NYSE: SNN) announced a transaction, but the medical device manufacturer is back on the acquisition trail. On September 29, the company purchased Integra LifeSciences Holdings Corporation’s (NASDAQ: IART) extremity orthopedics business for $240 million. The business includes a portfolio of devices, implants and instruments for shoulder replacement as well as reconstruction of bone in the hand, wrist and elbow, and foot and ankle. This deal will significantly strengthen Smith & Nephew’s extremities business by adding a combination of a focused sales channel, complementary shoulder replacement and upper and lower extremities... Read More »
Smith & Nephew Returns to the M&A Market

Smith & Nephew Acquires Robotics Firm Atracsys

Smith & Nephew plc (NYSE: SNN) has been on a shopping spree this year. After reporting two deals in March and a third in April, they’re at it again. Now the medical device maker has acquired Atracsys Sarl, a Swiss medical device firm with a focus on robotics. The company provides optical navigation and robotic tracking components with applications in orthopedics, neurosurgery, spine and dental and other computer-assisted surgical procedures. Atracsys’ FusionTrack 500 optical tracking camera will be a core enabling technology for Smith & Nephew’s multi-asset digital surgery and robotic ecosystem. This transaction meshes well with a recent purchase in particular. No... Read More »
Orthopedic Device Companies Are all the Rage in 2019

Orthopedic Device Companies Are all the Rage in 2019

Stryker Corporation’s (NYSE: SYK) recently announced acquisition of OrthoSpace, Ltd., an Israeli based orthopedic company, for $110 million (with another $110 million in milestones), makes it tough to ignore 2019’s biggest trend in the medical device sector. Orthopedic companies, so far, have taken up nearly 40% of the medical device transactions this year. In the deal, Stryker gains OrthoSpace’s InSpace platform, a biodegradable sub-acromial spacer designed to realign the natural biomechanics of the shoulder. It expects the InSpace product will bolster its sports medicine portfolio in particular. The product has been used with 20,000 patients across 30 countries.... Read More »